Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eliezer Mendel Van Allen, M.D.

Title
Institution
Department
Address
Phone

Overview

Mentoring
Dissecting Genomic Determinants of Response to Platinum-based Chemotherapy in Advanced NSCLC and Colorectal Cancer
Part Time, 01/01/17 - 12/31/17
Transcriptomic Correlates of Response to Immune Checkpoint Therapies in Melanoma
Soma Weiss, 01/01/18 - 12/28/18
Expanding accessibility of a molecular oncology almanac for precision cancer medicine
Soma Weiss, 08/06/18 - 08/02/19
Genomic predictors of response to CTLA4 blockade in metastatic melanoma
Summer, 06/15/15 - 08/30/15
Intron retention as a novel source of tumor neoantigens associated with response to checkpoint inhibitor therapy
Summer, 02/01/16 - 12/31/16

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01CA279221 (VAN ALLEN, ELIEZER M) Apr 1, 2024 - Mar 31, 2029
    NIH
    Dissecting Integrated Cellular Programs Promoting Platinum Resistance and Progression in Bladder Cancer
    Role: Principal Investigator
  2. R01CA278980 (VAN ALLEN, ELIEZER M) Jan 1, 2024 - Dec 31, 2028
    NIH
    Dissecting Convergent Somatic and Germline Alterations that Mediate the Origins and Evolution of Kidney Cancer
    Role: Principal Investigator
  3. U2CCA252974 (JANEWAY, KATHERINE A) Sep 1, 2020 - Aug 31, 2026
    NIH
    Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults
    Role: Co-Principal Investigator
  4. R21CA242861 (VAN ALLEN, ELIEZER M) Jul 1, 2019 - Jun 30, 2021
    NIH
    A statistical framework to systematically characterize cancer driver mutations in noncoding genomic regions
    Role: Principal Investigator
  5. U2CCA233195 (JOHNSON, BRUCE E.) Sep 24, 2018 - Aug 31, 2024
    NIH
    The Cellular Geography of Therapeutic Resistance in Cancer
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Updating...
This operation might take several minutes to complete. Please do not close your browser.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Van Allen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (595)
Explore
_
Co-Authors (396)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.